Acute Viral Bronchiolitis
10
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (10)
Respiratory Physiotherapy and Hospitalization in Infants With Bronchiolitis
Prone Position in Acute Bronchiolitis
NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study
Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis
HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis
Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis
Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis
High Flow Therapy vs Hypertonic Saline in Bronchiolitis
KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis